51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01639573 (ClinicalTrials.gov)	April 2011	18/6/2012	Campath-1h Phase I/II Pilot Trial as Immunoablative Therapy for Refractory Systemic Sclerosis	Campath-1h as Immunoablative Therapy for Children and Adolescents With Treatment Refractory Systemic ...	Scleroderma	Drug: Campath	Children's Hospital Los Angeles	NULL	Withdrawn	8 Years	18 Years	All	0	Phase 1/2	United States
2	NCT00684255 (ClinicalTrials.gov)	August 2007	22/5/2008	Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic ...	Reduced Intensity Conditioning And Allogeneic Stem Cell Transplantation in Patients With Medically R ...	Systemic Lupus Erythematosus;Systemic Sclerosis	Procedure: Reduced Intensity Allogeneic Transplant;Drug: Fludarabine;Drug: Busulfan;Drug: Campath	New York Medical College	NULL	Terminated	7 Years	50 Years	All	1	Phase 1	United States

First Previous1Next Last